Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
2
×
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
amarna therapeutics
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
biofourmis
biontech
biotech
boehringer ingelheim
boston
boston pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
casdin capital
chronic kidney disease
clene nanomedicine
clinical trials
corvex management
covid-19
curevac
cystic fibrosis
deals
detroit blog main
detroit top stories
What
bio
2
×
cancer
2
×
abbvie’s
ahead
bets
biofourmis
bucks
celebrate
chance
comes
companies
corner
cut
date
day
days
deal
effective
enticed
evidence
forward
hasn’t
holiday
labor
latest
looking
medicines
messenger
molecules
mrna
multiple
new
people
pharma
pharmaceutical
primarily
promise
proven
rna
roundup
Language
unset
Current search:
sanofi
×
cancer
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines